Sponsor Pipeline

Zhiguo Luo, MD, PhD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06869174 Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary Cancer of Unknown Primary Not Yet Recruiting
Get alerts when Zhiguo Luo, MD, PhD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free